tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MORF Stock Latest News

M&A News: Eli Lilly Snaps Up Morphic in $3.2B Deal
Market NewsM&A News: Eli Lilly Snaps Up Morphic in $3.2B Deal
7h ago
LLY
MORF
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
PremiumPress Releases
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
10h ago
LLY
MORF
Morphic to Participate in Jefferies Global Healthcare Conference
PremiumPress Releases
Morphic to Participate in Jefferies Global Healthcare Conference
1M ago
MORF
Morphic demonstrates real-time visual of small molecule alpha4beta7 inhibition
PremiumThe Fly
Morphic demonstrates real-time visual of small molecule alpha4beta7 inhibition
2M ago
MORF
Morphic Holding Launches New Stock Offering, Ends Previous Deal
PremiumCompany Announcements
Morphic Holding Launches New Stock Offering, Ends Previous Deal
2M ago
8K
MORF
Morphic files automatic mixed securities shelf
PremiumThe FlyMorphic files automatic mixed securities shelf
2M ago
MORF
Morphic reports Q1 EPS (91c), consensus (93c)
PremiumThe Fly
Morphic reports Q1 EPS (91c), consensus (93c)
2M ago
MORF
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
PremiumPress Releases
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
2M ago
MORF
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
PremiumPress Releases
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
4M ago
MORF
Morphic appoints Cooper as Chief Medical Officer
PremiumThe Fly
Morphic appoints Cooper as Chief Medical Officer
4M ago
KROS
MORF
Morphic Holding Unveils Updated Corporate Presentation
PremiumCompany Announcements
Morphic Holding Unveils Updated Corporate Presentation
4M ago
8K
MORF
Morphic price target lowered to $66 from $68 at Canaccord
PremiumThe Fly
Morphic price target lowered to $66 from $68 at Canaccord
4M ago
MORF
Morphic to Participate in March Investor Conferences
PremiumPress ReleasesMorphic to Participate in March Investor Conferences
4M ago
MORF
Morphic price target lowered to $64 from $67 at Wells Fargo
PremiumThe Fly
Morphic price target lowered to $64 from $67 at Wells Fargo
5M ago
MORF
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
PremiumPress Releases
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
5M ago
MORF
Morphic reports FY23 revenue $521,000, consensus $500,000
PremiumThe Fly
Morphic reports FY23 revenue $521,000, consensus $500,000
5M ago
MORF
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
6M ago
MORF
Morphic initiated with bullish view at Citi, here’s why
PremiumThe Fly
Morphic initiated with bullish view at Citi, here’s why
7M ago
MORF
TD Cowen starts ‘only pure-play TL1A company’ Spyre Therapeutics at Outperform
PremiumThe Fly
TD Cowen starts ‘only pure-play TL1A company’ Spyre Therapeutics at Outperform
7M ago
IMVT
MORF
Morphic price target lowered to $76 from $80 at RBC Capital
PremiumThe FlyMorphic price target lowered to $76 from $80 at RBC Capital
8M ago
MORF
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
PremiumPress Releases
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
8M ago
MORF
Morphic expects cash to fund operations through second half of 2027
PremiumThe Fly
Morphic expects cash to fund operations through second half of 2027
8M ago
MORF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >